Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/MH/154 (ERM Project ID 38427)
NMA SSA Reference Number: SSA/38427/MonH-2019-170798(v1)
Monash Health Ref: RES-19-0000-279X
StatusActive
Effective start/end date20/05/1919/05/24

Keywords

  • clinical trial
  • brain cancer
  • treatment efficacy